Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Obesity is in epidemic proportions in many parts of the world, contributing to increasing rates of non-alcoholic fatty liver disease (NAFLD). NAFLD represents a range of conditions from the initial stage of fatty liver to non-alcoholic steatohepatitis (NASH), which can progress to severe fibrosis, t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Antioxidants
المؤلفون الرئيسيون: Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2024-04-01
الموضوعات:
ellagic acid
urolithins
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
dietarily interventions
الوصول للمادة أونلاين:https://www.mdpi.com/2076-3921/13/4/485

الانترنت

https://www.mdpi.com/2076-3921/13/4/485

مواد مشابهة